
NQO1 Stabilizes p53 in Response to Oncogene-Induced Senescence
2015年5月21日 · quinone oxidoreductase 1 (NQO1), a cytoplasmic 2-electron reductase, is induced during oncogene-induced senescence (OIS). Depletion of NQO1 resulted in the delayed onset of senescence. In contrast, ectopic expression of NQO1 enhanced the senescence phenotype. Analysis of the mechanism underlying the …
NQO1: A target for the treatment of cancer and neurological diseases ...
2019年7月1日 · NAD (P)H quinone oxidoreductase 1 (NQO1) is a multi-functional protein that catalyses the reduction of quinones (and other molecules), thus playing roles in xenobiotic detoxification and redox balance, and also has roles in stabilising apoptosis regulators such as …
Frontiers | Functions of NQO1 in Cellular Protection and CoQ10 ...
NQO1 is one of the two major quinone reductases in mammalian systems. It is highly inducible and plays multiple roles in cellular adaptation to stress. A prevalent polymorphic form of NQO1 results in an absence of NQO1 protein and activity so it is important to elucidate the specific cellular functions of NQO1.
Discovery of Natural Products Targeting NQO1 via an Approach
2021年5月24日 · NAD (P)H:quinone oxidoreductase 1 (NQO1) has been shown to be a potential therapeutic target for various human diseases, such as cancer and neurodegenerative disorders. Recent advances in computational methods, especially network-based methods, have made it possible to identify novel compounds for a target with high efficiency and low cost.
Nociceptin receptor - Wikipedia
The nociceptin opioid peptide receptor (NOP), also known as the nociceptin/orphanin FQ (N/OFQ) receptor or kappa-type 3 opioid receptor, is a protein that in humans is encoded by the OPRL1 (opioid receptor-like 1) gene. [5] .
Therapeutic potentials of NOP and MOP receptor coactivation for …
Following the identification of the nociceptin/orphanin FQ (N/OFQ) peptide (NOP) as an endogenous ligand for the NOP receptor, ample evidence has revealed unique functional profiles of the N/OFQ-NOP receptor system. NOP receptors are expressed in key neural substrates involved in pain and reward modulation.
Nociceptin/Orphanin FQ-NOP Receptor System in ... - ScienceDirect
2015年1月1日 · Cells from the immune system express the precursor preproN/OFQ and the NOP receptor, as well as secrete N/OFQ. The activation of the N/OFQ-NOP pathway can regulate inflammatory and immune responses.
LM5122QMHX/NOPB_TI (德州仪器)_LM5122QMHX/NOPB中文 …
该控制器支持多相配置,峰值电流模式控制,内置强大的N沟道MOSFET驱动器和自适应死区时间控制。 开关频率可编程至1MHz,具有可选的二极管仿真模式和多种保护功能。 LM5122QMHX/NOPB由TI (德州仪器)设计生产,立创商城现货销售。 LM5122QMHX/NOPB价格参考¥10.82。 TI (德州仪器) LM5122QMHX/NOPB参数名称:功能类型:升压型;工作电压:4.5V~65V;开关频率:1MHz;工作温度:-40℃~+125℃@ (TJ);同步整流:是;输出通道数:1;拓扑结构:升 …
Therapeutic potential of nociceptin/orphanin FQ peptide (NOP) …
伤害感受肽/孤啡肽 FQ (N/OFQ) 肽 (NOP) 受体是阿片受体超家族的成员,N/OFQ 为其内源性激动剂。 NOP 受体和 N/OFQ 在中枢和外周的广泛表达,以及它们调节多种生物功能的能力,导致制药公司根据其在疼痛、焦虑、焦虑等临床前模型中的功效,开发了 NOP 受体调节剂作为治疗剂。 抑郁症、帕金森病和药物滥用。 创伤后应激障碍 (PTSD) 和创伤性脑损伤 (TBI) 都是使人衰弱的疾病,严重影响全世界数百万人的生活质量。 创伤后应激障碍 (PTSD) 和创伤性脑损伤 (TBI) 均由 …
The effects of nociceptin peptide (N/OFQ)–receptor (NOP) system ...
2013年1月1日 · This review collates the available evidence for a role of the non-classical opioid receptor NOP in regulation of airway physiology. N/OFQ has both bronchodilatory and immunomodulatory properties. N/OFQ–NOP system is a novel target worthy of investigation in airway disease. 1. N/OFQ and NOP receptor.